Global Precision Cancer Medicine Market Growth (Status and Outlook) 2026-2032
The global Precision Cancer Medicine market size is predicted to grow from US$ 209360 million in 2025 to US$ 483770 million in 2032; it is expected to grow at a CAGR of 13.0% from 2026 to 2032.
Precision cancer medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient"s cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient"s tumor.
Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer"s molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual"s specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.
LPI (LP Information)' newest research report, the “Precision Cancer Medicine Industry Forecast” looks at past sales and reviews total world Precision Cancer Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Precision Cancer Medicine sales for 2026 through 2032. With Precision Cancer Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Cancer Medicine industry.
This Insight Report provides a comprehensive analysis of the global Precision Cancer Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Cancer Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Cancer Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Cancer Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Cancer Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Precision Cancer Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
Precision cancer medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient"s cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient"s tumor.
Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer"s molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual"s specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.
LPI (LP Information)' newest research report, the “Precision Cancer Medicine Industry Forecast” looks at past sales and reviews total world Precision Cancer Medicine sales in 2025, providing a comprehensive analysis by region and market sector of projected Precision Cancer Medicine sales for 2026 through 2032. With Precision Cancer Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Precision Cancer Medicine industry.
This Insight Report provides a comprehensive analysis of the global Precision Cancer Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Precision Cancer Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Precision Cancer Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Precision Cancer Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Precision Cancer Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Precision Cancer Medicine market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Cancer Immunotherapy
- Targeted Therapy
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Blood-related Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- GSK
- Exelixis
- Regeneron
- Innovent
- Hengrui Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Precision Cancer Medicine Market Size (2021-2032)
2.1.2 Precision Cancer Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Precision Cancer Medicine by Country/Region (2021, 2025 & 2032)
2.2 Precision Cancer Medicine Segment by Type
2.2.1 Cancer Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Precision Cancer Medicine Market Size by Type
2.2.3.1 Precision Cancer Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
2.3 Precision Cancer Medicine Segment by Application
2.3.1 Lung Cancer
2.3.2 Breast Cancer
2.3.3 Prostate Cancer
2.3.4 Blood-related Cancer
2.3.5 Other
2.3.6 Precision Cancer Medicine Market Size by Application
2.3.6.1 Precision Cancer Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
3 PRECISION CANCER MEDICINE MARKET SIZE BY PLAYER
3.1 Precision Cancer Medicine Market Size Market Share by Player
3.1.1 Global Precision Cancer Medicine Revenue by Player (2021-2026)
3.1.2 Global Precision Cancer Medicine Revenue Market Share by Player (2021-2026)
3.2 Global Precision Cancer Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRECISION CANCER MEDICINE BY REGION
4.1 Precision Cancer Medicine Market Size by Region (2021-2026)
4.2 Global Precision Cancer Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Precision Cancer Medicine Market Size Growth (2021-2026)
4.4 APAC Precision Cancer Medicine Market Size Growth (2021-2026)
4.5 Europe Precision Cancer Medicine Market Size Growth (2021-2026)
4.6 Middle East & Africa Precision Cancer Medicine Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Precision Cancer Medicine Market Size by Country (2021-2026)
5.2 Americas Precision Cancer Medicine Market Size by Type (2021-2026)
5.3 Americas Precision Cancer Medicine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Precision Cancer Medicine Market Size by Region (2021-2026)
6.2 APAC Precision Cancer Medicine Market Size by Type (2021-2026)
6.3 APAC Precision Cancer Medicine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Precision Cancer Medicine Market Size by Country (2021-2026)
7.2 Europe Precision Cancer Medicine Market Size by Type (2021-2026)
7.3 Europe Precision Cancer Medicine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Precision Cancer Medicine by Region (2021-2026)
8.2 Middle East & Africa Precision Cancer Medicine Market Size by Type (2021-2026)
8.3 Middle East & Africa Precision Cancer Medicine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRECISION CANCER MEDICINE MARKET FORECAST
10.1 Global Precision Cancer Medicine Forecast by Region (2027-2032)
10.1.1 Global Precision Cancer Medicine Forecast by Region (2027-2032)
10.1.2 Americas Precision Cancer Medicine Forecast
10.1.3 APAC Precision Cancer Medicine Forecast
10.1.4 Europe Precision Cancer Medicine Forecast
10.1.5 Middle East & Africa Precision Cancer Medicine Forecast
10.2 Americas Precision Cancer Medicine Forecast by Country (2027-2032)
10.2.1 United States Market Precision Cancer Medicine Forecast
10.2.2 Canada Market Precision Cancer Medicine Forecast
10.2.3 Mexico Market Precision Cancer Medicine Forecast
10.2.4 Brazil Market Precision Cancer Medicine Forecast
10.3 APAC Precision Cancer Medicine Forecast by Region (2027-2032)
10.3.1 China Precision Cancer Medicine Market Forecast
10.3.2 Japan Market Precision Cancer Medicine Forecast
10.3.3 Korea Market Precision Cancer Medicine Forecast
10.3.4 Southeast Asia Market Precision Cancer Medicine Forecast
10.3.5 India Market Precision Cancer Medicine Forecast
10.3.6 Australia Market Precision Cancer Medicine Forecast
10.4 Europe Precision Cancer Medicine Forecast by Country (2027-2032)
10.4.1 Germany Market Precision Cancer Medicine Forecast
10.4.2 France Market Precision Cancer Medicine Forecast
10.4.3 UK Market Precision Cancer Medicine Forecast
10.4.4 Italy Market Precision Cancer Medicine Forecast
10.4.5 Russia Market Precision Cancer Medicine Forecast
10.5 Middle East & Africa Precision Cancer Medicine Forecast by Region (2027-2032)
10.5.1 Egypt Market Precision Cancer Medicine Forecast
10.5.2 South Africa Market Precision Cancer Medicine Forecast
10.5.3 Israel Market Precision Cancer Medicine Forecast
10.5.4 Turkey Market Precision Cancer Medicine Forecast
10.6 Global Precision Cancer Medicine Forecast by Type (2027-2032)
10.7 Global Precision Cancer Medicine Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Precision Cancer Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Precision Cancer Medicine Product Offered
11.1.3 AbbVie Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Precision Cancer Medicine Product Offered
11.2.3 Johnson & Johnson Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Precision Cancer Medicine Product Offered
11.3.3 Novartis Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Precision Cancer Medicine Product Offered
11.4.3 Gilead Sciences Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Precision Cancer Medicine Product Offered
11.5.3 Roche Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Precision Cancer Medicine Product Offered
11.6.3 Bristol-Myers Squibb Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Precision Cancer Medicine Product Offered
11.7.3 Amgen Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Precision Cancer Medicine Product Offered
11.8.3 AstraZeneca Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Precision Cancer Medicine Product Offered
11.9.3 Merck & Co Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Precision Cancer Medicine Product Offered
11.10.3 Takeda Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Precision Cancer Medicine Product Offered
11.11.3 Merck KGaA Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Precision Cancer Medicine Product Offered
11.12.3 Seagen Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Precision Cancer Medicine Product Offered
11.13.3 Eli Lilly Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Precision Cancer Medicine Product Offered
11.14.3 Ono Pharmaceutical Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Precision Cancer Medicine Product Offered
11.15.3 Pfizer Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Precision Cancer Medicine Product Offered
11.16.3 GSK Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
11.17 Exelixis
11.17.1 Exelixis Company Information
11.17.2 Exelixis Precision Cancer Medicine Product Offered
11.17.3 Exelixis Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Exelixis Main Business Overview
11.17.5 Exelixis Latest Developments
11.18 Regeneron
11.18.1 Regeneron Company Information
11.18.2 Regeneron Precision Cancer Medicine Product Offered
11.18.3 Regeneron Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Regeneron Main Business Overview
11.18.5 Regeneron Latest Developments
11.19 Innovent
11.19.1 Innovent Company Information
11.19.2 Innovent Precision Cancer Medicine Product Offered
11.19.3 Innovent Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Innovent Main Business Overview
11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Precision Cancer Medicine Product Offered
11.20.3 Hengrui Medicine Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Precision Cancer Medicine Market Size (2021-2032)
2.1.2 Precision Cancer Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Precision Cancer Medicine by Country/Region (2021, 2025 & 2032)
2.2 Precision Cancer Medicine Segment by Type
2.2.1 Cancer Immunotherapy
2.2.2 Targeted Therapy
2.2.3 Precision Cancer Medicine Market Size by Type
2.2.3.1 Precision Cancer Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
2.3 Precision Cancer Medicine Segment by Application
2.3.1 Lung Cancer
2.3.2 Breast Cancer
2.3.3 Prostate Cancer
2.3.4 Blood-related Cancer
2.3.5 Other
2.3.6 Precision Cancer Medicine Market Size by Application
2.3.6.1 Precision Cancer Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
3 PRECISION CANCER MEDICINE MARKET SIZE BY PLAYER
3.1 Precision Cancer Medicine Market Size Market Share by Player
3.1.1 Global Precision Cancer Medicine Revenue by Player (2021-2026)
3.1.2 Global Precision Cancer Medicine Revenue Market Share by Player (2021-2026)
3.2 Global Precision Cancer Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PRECISION CANCER MEDICINE BY REGION
4.1 Precision Cancer Medicine Market Size by Region (2021-2026)
4.2 Global Precision Cancer Medicine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Precision Cancer Medicine Market Size Growth (2021-2026)
4.4 APAC Precision Cancer Medicine Market Size Growth (2021-2026)
4.5 Europe Precision Cancer Medicine Market Size Growth (2021-2026)
4.6 Middle East & Africa Precision Cancer Medicine Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Precision Cancer Medicine Market Size by Country (2021-2026)
5.2 Americas Precision Cancer Medicine Market Size by Type (2021-2026)
5.3 Americas Precision Cancer Medicine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Precision Cancer Medicine Market Size by Region (2021-2026)
6.2 APAC Precision Cancer Medicine Market Size by Type (2021-2026)
6.3 APAC Precision Cancer Medicine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Precision Cancer Medicine Market Size by Country (2021-2026)
7.2 Europe Precision Cancer Medicine Market Size by Type (2021-2026)
7.3 Europe Precision Cancer Medicine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Precision Cancer Medicine by Region (2021-2026)
8.2 Middle East & Africa Precision Cancer Medicine Market Size by Type (2021-2026)
8.3 Middle East & Africa Precision Cancer Medicine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PRECISION CANCER MEDICINE MARKET FORECAST
10.1 Global Precision Cancer Medicine Forecast by Region (2027-2032)
10.1.1 Global Precision Cancer Medicine Forecast by Region (2027-2032)
10.1.2 Americas Precision Cancer Medicine Forecast
10.1.3 APAC Precision Cancer Medicine Forecast
10.1.4 Europe Precision Cancer Medicine Forecast
10.1.5 Middle East & Africa Precision Cancer Medicine Forecast
10.2 Americas Precision Cancer Medicine Forecast by Country (2027-2032)
10.2.1 United States Market Precision Cancer Medicine Forecast
10.2.2 Canada Market Precision Cancer Medicine Forecast
10.2.3 Mexico Market Precision Cancer Medicine Forecast
10.2.4 Brazil Market Precision Cancer Medicine Forecast
10.3 APAC Precision Cancer Medicine Forecast by Region (2027-2032)
10.3.1 China Precision Cancer Medicine Market Forecast
10.3.2 Japan Market Precision Cancer Medicine Forecast
10.3.3 Korea Market Precision Cancer Medicine Forecast
10.3.4 Southeast Asia Market Precision Cancer Medicine Forecast
10.3.5 India Market Precision Cancer Medicine Forecast
10.3.6 Australia Market Precision Cancer Medicine Forecast
10.4 Europe Precision Cancer Medicine Forecast by Country (2027-2032)
10.4.1 Germany Market Precision Cancer Medicine Forecast
10.4.2 France Market Precision Cancer Medicine Forecast
10.4.3 UK Market Precision Cancer Medicine Forecast
10.4.4 Italy Market Precision Cancer Medicine Forecast
10.4.5 Russia Market Precision Cancer Medicine Forecast
10.5 Middle East & Africa Precision Cancer Medicine Forecast by Region (2027-2032)
10.5.1 Egypt Market Precision Cancer Medicine Forecast
10.5.2 South Africa Market Precision Cancer Medicine Forecast
10.5.3 Israel Market Precision Cancer Medicine Forecast
10.5.4 Turkey Market Precision Cancer Medicine Forecast
10.6 Global Precision Cancer Medicine Forecast by Type (2027-2032)
10.7 Global Precision Cancer Medicine Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Precision Cancer Medicine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Precision Cancer Medicine Product Offered
11.1.3 AbbVie Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Precision Cancer Medicine Product Offered
11.2.3 Johnson & Johnson Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Precision Cancer Medicine Product Offered
11.3.3 Novartis Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Precision Cancer Medicine Product Offered
11.4.3 Gilead Sciences Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Precision Cancer Medicine Product Offered
11.5.3 Roche Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Precision Cancer Medicine Product Offered
11.6.3 Bristol-Myers Squibb Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Precision Cancer Medicine Product Offered
11.7.3 Amgen Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Precision Cancer Medicine Product Offered
11.8.3 AstraZeneca Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Precision Cancer Medicine Product Offered
11.9.3 Merck & Co Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Precision Cancer Medicine Product Offered
11.10.3 Takeda Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Precision Cancer Medicine Product Offered
11.11.3 Merck KGaA Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Precision Cancer Medicine Product Offered
11.12.3 Seagen Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Precision Cancer Medicine Product Offered
11.13.3 Eli Lilly Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Precision Cancer Medicine Product Offered
11.14.3 Ono Pharmaceutical Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Precision Cancer Medicine Product Offered
11.15.3 Pfizer Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Precision Cancer Medicine Product Offered
11.16.3 GSK Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
11.17 Exelixis
11.17.1 Exelixis Company Information
11.17.2 Exelixis Precision Cancer Medicine Product Offered
11.17.3 Exelixis Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Exelixis Main Business Overview
11.17.5 Exelixis Latest Developments
11.18 Regeneron
11.18.1 Regeneron Company Information
11.18.2 Regeneron Precision Cancer Medicine Product Offered
11.18.3 Regeneron Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Regeneron Main Business Overview
11.18.5 Regeneron Latest Developments
11.19 Innovent
11.19.1 Innovent Company Information
11.19.2 Innovent Precision Cancer Medicine Product Offered
11.19.3 Innovent Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Innovent Main Business Overview
11.19.5 Innovent Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Precision Cancer Medicine Product Offered
11.20.3 Hengrui Medicine Precision Cancer Medicine Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Precision Cancer Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Precision Cancer Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cancer Immunotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Precision Cancer Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Table 8. Precision Cancer Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Table 11. Global Precision Cancer Medicine Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Precision Cancer Medicine Revenue Market Share by Player (2021-2026)
Table 13. Precision Cancer Medicine Key Players Head office and Products Offered
Table 14. Precision Cancer Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Table 19. Global Precision Cancer Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Precision Cancer Medicine Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Precision Cancer Medicine Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Precision Cancer Medicine Market Size Market Share by Country (2021-2026)
Table 23. Americas Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Table 25. Americas Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Table 27. APAC Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Table 29. APAC Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Precision Cancer Medicine Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Precision Cancer Medicine Market Size Market Share by Country (2021-2026)
Table 33. Europe Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Precision Cancer Medicine
Table 39. Key Market Challenges & Risks of Precision Cancer Medicine
Table 40. Key Industry Trends of Precision Cancer Medicine
Table 41. Global Precision Cancer Medicine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Precision Cancer Medicine Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Precision Cancer Medicine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Precision Cancer Medicine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 46. AbbVie Precision Cancer Medicine Product Offered
Table 47. AbbVie Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Johnson & Johnson Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 51. Johnson & Johnson Precision Cancer Medicine Product Offered
Table 52. Johnson & Johnson Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Johnson & Johnson Main Business
Table 54. Johnson & Johnson Latest Developments
Table 55. Novartis Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 56. Novartis Precision Cancer Medicine Product Offered
Table 57. Novartis Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Gilead Sciences Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 61. Gilead Sciences Precision Cancer Medicine Product Offered
Table 62. Gilead Sciences Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Latest Developments
Table 65. Roche Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 66. Roche Precision Cancer Medicine Product Offered
Table 67. Roche Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Roche Main Business
Table 69. Roche Latest Developments
Table 70. Bristol-Myers Squibb Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 71. Bristol-Myers Squibb Precision Cancer Medicine Product Offered
Table 72. Bristol-Myers Squibb Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bristol-Myers Squibb Main Business
Table 74. Bristol-Myers Squibb Latest Developments
Table 75. Amgen Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 76. Amgen Precision Cancer Medicine Product Offered
Table 77. Amgen Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Amgen Main Business
Table 79. Amgen Latest Developments
Table 80. AstraZeneca Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 81. AstraZeneca Precision Cancer Medicine Product Offered
Table 82. AstraZeneca Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Merck & Co Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 86. Merck & Co Precision Cancer Medicine Product Offered
Table 87. Merck & Co Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Merck & Co Main Business
Table 89. Merck & Co Latest Developments
Table 90. Takeda Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 91. Takeda Precision Cancer Medicine Product Offered
Table 92. Takeda Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Merck KGaA Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 96. Merck KGaA Precision Cancer Medicine Product Offered
Table 97. Merck KGaA Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Merck KGaA Main Business
Table 99. Merck KGaA Latest Developments
Table 100. Seagen Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 101. Seagen Precision Cancer Medicine Product Offered
Table 102. Seagen Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Seagen Main Business
Table 104. Seagen Latest Developments
Table 105. Eli Lilly Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 106. Eli Lilly Precision Cancer Medicine Product Offered
Table 107. Eli Lilly Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Eli Lilly Main Business
Table 109. Eli Lilly Latest Developments
Table 110. Ono Pharmaceutical Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 111. Ono Pharmaceutical Precision Cancer Medicine Product Offered
Table 112. Ono Pharmaceutical Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Ono Pharmaceutical Main Business
Table 114. Ono Pharmaceutical Latest Developments
Table 115. Pfizer Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 116. Pfizer Precision Cancer Medicine Product Offered
Table 117. Pfizer Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. GSK Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 121. GSK Precision Cancer Medicine Product Offered
Table 122. GSK Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. GSK Main Business
Table 124. GSK Latest Developments
Table 125. Exelixis Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 126. Exelixis Precision Cancer Medicine Product Offered
Table 127. Exelixis Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Exelixis Main Business
Table 129. Exelixis Latest Developments
Table 130. Regeneron Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 131. Regeneron Precision Cancer Medicine Product Offered
Table 132. Regeneron Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Regeneron Main Business
Table 134. Regeneron Latest Developments
Table 135. Innovent Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 136. Innovent Precision Cancer Medicine Product Offered
Table 137. Innovent Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Innovent Main Business
Table 139. Innovent Latest Developments
Table 140. Hengrui Medicine Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 141. Hengrui Medicine Precision Cancer Medicine Product Offered
Table 142. Hengrui Medicine Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Hengrui Medicine Main Business
Table 144. Hengrui Medicine Latest Developments
Table 1. Precision Cancer Medicine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Precision Cancer Medicine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Cancer Immunotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Precision Cancer Medicine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Table 8. Precision Cancer Medicine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Table 11. Global Precision Cancer Medicine Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Precision Cancer Medicine Revenue Market Share by Player (2021-2026)
Table 13. Precision Cancer Medicine Key Players Head office and Products Offered
Table 14. Precision Cancer Medicine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Table 19. Global Precision Cancer Medicine Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Precision Cancer Medicine Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Precision Cancer Medicine Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Precision Cancer Medicine Market Size Market Share by Country (2021-2026)
Table 23. Americas Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Table 25. Americas Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Table 27. APAC Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Table 29. APAC Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Precision Cancer Medicine Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Precision Cancer Medicine Market Size Market Share by Country (2021-2026)
Table 33. Europe Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Precision Cancer Medicine Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Precision Cancer Medicine Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Precision Cancer Medicine Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Precision Cancer Medicine
Table 39. Key Market Challenges & Risks of Precision Cancer Medicine
Table 40. Key Industry Trends of Precision Cancer Medicine
Table 41. Global Precision Cancer Medicine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Precision Cancer Medicine Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Precision Cancer Medicine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Precision Cancer Medicine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. AbbVie Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 46. AbbVie Precision Cancer Medicine Product Offered
Table 47. AbbVie Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. AbbVie Main Business
Table 49. AbbVie Latest Developments
Table 50. Johnson & Johnson Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 51. Johnson & Johnson Precision Cancer Medicine Product Offered
Table 52. Johnson & Johnson Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Johnson & Johnson Main Business
Table 54. Johnson & Johnson Latest Developments
Table 55. Novartis Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 56. Novartis Precision Cancer Medicine Product Offered
Table 57. Novartis Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Novartis Main Business
Table 59. Novartis Latest Developments
Table 60. Gilead Sciences Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 61. Gilead Sciences Precision Cancer Medicine Product Offered
Table 62. Gilead Sciences Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Latest Developments
Table 65. Roche Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 66. Roche Precision Cancer Medicine Product Offered
Table 67. Roche Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Roche Main Business
Table 69. Roche Latest Developments
Table 70. Bristol-Myers Squibb Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 71. Bristol-Myers Squibb Precision Cancer Medicine Product Offered
Table 72. Bristol-Myers Squibb Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Bristol-Myers Squibb Main Business
Table 74. Bristol-Myers Squibb Latest Developments
Table 75. Amgen Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 76. Amgen Precision Cancer Medicine Product Offered
Table 77. Amgen Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Amgen Main Business
Table 79. Amgen Latest Developments
Table 80. AstraZeneca Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 81. AstraZeneca Precision Cancer Medicine Product Offered
Table 82. AstraZeneca Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. Merck & Co Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 86. Merck & Co Precision Cancer Medicine Product Offered
Table 87. Merck & Co Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Merck & Co Main Business
Table 89. Merck & Co Latest Developments
Table 90. Takeda Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 91. Takeda Precision Cancer Medicine Product Offered
Table 92. Takeda Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Takeda Main Business
Table 94. Takeda Latest Developments
Table 95. Merck KGaA Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 96. Merck KGaA Precision Cancer Medicine Product Offered
Table 97. Merck KGaA Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Merck KGaA Main Business
Table 99. Merck KGaA Latest Developments
Table 100. Seagen Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 101. Seagen Precision Cancer Medicine Product Offered
Table 102. Seagen Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Seagen Main Business
Table 104. Seagen Latest Developments
Table 105. Eli Lilly Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 106. Eli Lilly Precision Cancer Medicine Product Offered
Table 107. Eli Lilly Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Eli Lilly Main Business
Table 109. Eli Lilly Latest Developments
Table 110. Ono Pharmaceutical Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 111. Ono Pharmaceutical Precision Cancer Medicine Product Offered
Table 112. Ono Pharmaceutical Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Ono Pharmaceutical Main Business
Table 114. Ono Pharmaceutical Latest Developments
Table 115. Pfizer Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 116. Pfizer Precision Cancer Medicine Product Offered
Table 117. Pfizer Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. GSK Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 121. GSK Precision Cancer Medicine Product Offered
Table 122. GSK Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. GSK Main Business
Table 124. GSK Latest Developments
Table 125. Exelixis Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 126. Exelixis Precision Cancer Medicine Product Offered
Table 127. Exelixis Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Exelixis Main Business
Table 129. Exelixis Latest Developments
Table 130. Regeneron Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 131. Regeneron Precision Cancer Medicine Product Offered
Table 132. Regeneron Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Regeneron Main Business
Table 134. Regeneron Latest Developments
Table 135. Innovent Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 136. Innovent Precision Cancer Medicine Product Offered
Table 137. Innovent Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Innovent Main Business
Table 139. Innovent Latest Developments
Table 140. Hengrui Medicine Details, Company Type, Precision Cancer Medicine Area Served and Its Competitors
Table 141. Hengrui Medicine Precision Cancer Medicine Product Offered
Table 142. Hengrui Medicine Precision Cancer Medicine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Hengrui Medicine Main Business
Table 144. Hengrui Medicine Latest Developments
LIST OF FIGURES
Figure 1. Precision Cancer Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Precision Cancer Medicine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Precision Cancer Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Precision Cancer Medicine Sales Market Share by Country/Region (2025)
Figure 8. Precision Cancer Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Precision Cancer Medicine Market Size Market Share by Type in 2025
Figure 10. Precision Cancer Medicine in Lung Cancer
Figure 11. Global Precision Cancer Medicine Market: Lung Cancer (2021-2026) & ($ millions)
Figure 12. Precision Cancer Medicine in Breast Cancer
Figure 13. Global Precision Cancer Medicine Market: Breast Cancer (2021-2026) & ($ millions)
Figure 14. Precision Cancer Medicine in Prostate Cancer
Figure 15. Global Precision Cancer Medicine Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 16. Precision Cancer Medicine in Blood-related Cancer
Figure 17. Global Precision Cancer Medicine Market: Blood-related Cancer (2021-2026) & ($ millions)
Figure 18. Precision Cancer Medicine in Other
Figure 19. Global Precision Cancer Medicine Market: Other (2021-2026) & ($ millions)
Figure 20. Global Precision Cancer Medicine Market Size Market Share by Application in 2025
Figure 21. Global Precision Cancer Medicine Revenue Market Share by Player in 2025
Figure 22. Global Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Figure 23. Americas Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 24. APAC Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 25. Europe Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 27. Americas Precision Cancer Medicine Value Market Share by Country in 2025
Figure 28. United States Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Precision Cancer Medicine Market Size Market Share by Region in 2025
Figure 33. APAC Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 34. APAC Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 35. China Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 39. India Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Precision Cancer Medicine Market Size Market Share by Country in 2025
Figure 42. Europe Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 43. Europe Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 44. Germany Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 45. France Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 58. APAC Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 59. Europe Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 61. United States Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 62. Canada Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 63. Mexico Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 64. Brazil Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 65. China Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 66. Japan Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 67. Korea Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 69. India Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 70. Australia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 71. Germany Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 72. France Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 73. UK Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 74. Italy Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 75. Russia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 76. Egypt Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 77. South Africa Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 78. Israel Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 79. Turkey Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 80. Global Precision Cancer Medicine Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Precision Cancer Medicine Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 1. Precision Cancer Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Precision Cancer Medicine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Precision Cancer Medicine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Precision Cancer Medicine Sales Market Share by Country/Region (2025)
Figure 8. Precision Cancer Medicine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Precision Cancer Medicine Market Size Market Share by Type in 2025
Figure 10. Precision Cancer Medicine in Lung Cancer
Figure 11. Global Precision Cancer Medicine Market: Lung Cancer (2021-2026) & ($ millions)
Figure 12. Precision Cancer Medicine in Breast Cancer
Figure 13. Global Precision Cancer Medicine Market: Breast Cancer (2021-2026) & ($ millions)
Figure 14. Precision Cancer Medicine in Prostate Cancer
Figure 15. Global Precision Cancer Medicine Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 16. Precision Cancer Medicine in Blood-related Cancer
Figure 17. Global Precision Cancer Medicine Market: Blood-related Cancer (2021-2026) & ($ millions)
Figure 18. Precision Cancer Medicine in Other
Figure 19. Global Precision Cancer Medicine Market: Other (2021-2026) & ($ millions)
Figure 20. Global Precision Cancer Medicine Market Size Market Share by Application in 2025
Figure 21. Global Precision Cancer Medicine Revenue Market Share by Player in 2025
Figure 22. Global Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Figure 23. Americas Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 24. APAC Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 25. Europe Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Precision Cancer Medicine Market Size 2021-2026 ($ millions)
Figure 27. Americas Precision Cancer Medicine Value Market Share by Country in 2025
Figure 28. United States Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Precision Cancer Medicine Market Size Market Share by Region in 2025
Figure 33. APAC Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 34. APAC Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 35. China Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 39. India Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Precision Cancer Medicine Market Size Market Share by Country in 2025
Figure 42. Europe Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 43. Europe Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 44. Germany Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 45. France Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Precision Cancer Medicine Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Precision Cancer Medicine Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 58. APAC Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 59. Europe Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 61. United States Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 62. Canada Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 63. Mexico Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 64. Brazil Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 65. China Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 66. Japan Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 67. Korea Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 69. India Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 70. Australia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 71. Germany Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 72. France Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 73. UK Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 74. Italy Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 75. Russia Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 76. Egypt Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 77. South Africa Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 78. Israel Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 79. Turkey Precision Cancer Medicine Market Size 2027-2032 ($ millions)
Figure 80. Global Precision Cancer Medicine Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Precision Cancer Medicine Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Precision Cancer Medicine Market Size 2027-2032 ($ millions)
